Pinsent Masons advises LoopUp Group Plc on its placing and admission to AIM

31 Aug 2016 | 04:22 pm |

International law firm Pinsent Masons has advised LoopUp Group plc on its £8.5m placing and admission to AIM.

LoopUp is a global software-as-a-service provider of remote meetings and is headquartered in Shoreditch, London. It employs approximately 100 people across offices in London, San Francisco, New York, Boston and Hong Kong.

The Pinsent Masons team advising on the transaction was led by corporate partner Russell Booker supported by Adam Murphy, Chris Watts, Philippa Ward and Charles Baker.

Commenting on the deal, Russell Booker, said: "It is fantastic to see LoopUp succeed as one of the first UK tech companies to IPO since the referendum to leave the EU."

The LoopUp product is designed to eliminate common frustrations associated with conference calls. The placing proceeds are intended to be used to introduce inbound marketing, expand the sales team and also increase access through online distribution.

LoopUp's Co-CEO, Steve Flavell, said:  

"We were impressed with the team at Pinsent Masons which guided us through what was a complex and, at times, difficult process. In particular we would highlight their tech-sector expertise which helped them provide us simple, clear advice when called for."

Latest press releases

Show me all press releases

Pinsent Masons advises NTR plc on 54MW portfolio of co-located solar and battery storage projects in Ireland

Multinational law firm Pinsent Masons has advised NTR PLC on the acquisition of a 54MW portfolio of co-located solar and battery storage projects in County Wexford, Ireland, from renewable energy developer RES.

Pinsent Masons advises on Four Seasons Care Homes portfolio migration

Multinational law firm Pinsent Masons has advised propco investor LDC Care Homes and its asset and investment manager Elevation Advisors on the migration of a care homes portfolio from Four Seasons Health Care Group (FSHC) to new operators.

Pinsent Masons advises Teva Pharmaceuticals on €84m sale of its consumer healthcare brand portfolio to Karo Pharma AB.

Multinational law firm Pinsent Masons has advised Teva Pharmaceuticals’ subsidiary, Actavis Group PTC, on the successful €84m sale of a suite of consumer healthcare products to Karo Pharma AB (Karo).

People who viewed this press release also viewed

Show me all press releases

Pinsent Masons announces launch of Netherlands presence

Multinational law firm Pinsent Masons has announced plans to launch a presence in Amsterdam, its first office in the Netherlands.

Pinsent Masons advises on 5G Create - the £28m government funded 5G test projects

Multinational law firm Pinsent Masons has advised the Department for Digital, Culture, Media and Sport (DCMS) on its innovative joint £28m investment in 5G test projects to showcase the capability of 5G technology across a range of industries and identify commercially sustainable long-term use cases.

Pinsent Masons advises GNA Biosolutions GmbH on Covid-19 rapid PCR test

Multinational law firm Pinsent Masons advised GNA Biosolutions GmbH on IP and commercial aspects of its rapid PCR Covid-19 test.

For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on

+44 (0)20 7418 8199 or 

Location contacts